IPSC vs MTCH · rev $6.6M vs P/E 13, rev $3.48B
Century Therapeutics Inc (IPSC) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
IPSC currently screens at market cap $47.8M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the IPSC and MTCH stock pages for the full models.
Not investment advice.